Leading pharmaceutical firms seek risk-averse management

Major Korean drugmakers – Dong-A Pharmaceutical and Yuhan Corporation - are expected to become more conservative this year in the wake of ever-increasing bankruptcies in the wholesaling sector, strengthening risk management and reduce possible losses, according to market sources.

These companies have intensively supplied their pharmaceuticals to reliable wholesalers with better finance state...